Iofina (IOF) Share Price, News & Analysis

Company Overview

Iofina plc is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products and derivatives. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities, Iofina Resources, and Iofina Chemical.

Key Stats

• Today's Range: 26.50 to 27.89
• 50-Day Range: 22.35 to 27.80
• 52-Week Range: 16.31 to 29
• Volume: 132,113 shs
• Average Volume: 347,350 shs
• Market Capitalization: £65.64 million
• P/E Ratio: 19.19
• Dividend Yield: 2.88%
• Price Target: GBX 37.50
• Consensus Rating: Buy

IOF Stock Analysis - Frequently Asked Questions

How have IOF shares performed this year?

Iofina's stock was trading at GBX 19 at the beginning of 2025. Since then, IOF stock has increased by 43.9% and is now trading at GBX 27.34.

How do I buy shares of Iofina?

Shares of IOF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Iofina own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Iofina investors own include MercadoLibre (MELI), Gem Diamonds (GEMD), Sociedad Quimica y Minera (SQM), Centamin (CEY), Strat Aero (AERO), Avino Silver & Gold Mines (ASM) and Alibaba Group (BABA).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Basic Materials
• Industry: Specialty Chemicals
• Sub-Industry: N/A
• Current Symbol: LON:IOF
• CIK: N/A
• Web: www.iofina.com
• Phone: 44 20 3006 3135
• Fax: N/A
• Employees: 95
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Iofina: GBX 37.50
• High Price Target: GBX 37.50
• Low Price Target: GBX 37.50
• Potential Upside/Downside: +37.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 1.42
• Trailing P/E Ratio: 19.19
• Forward P/E Ratio: 15.05
• P/E Growth: N/A
• Net Income: £4.28 million
• Net Margins: 6.98%
• Pretax Margin: N/A
• Return on Equity: 8.00%
• Return on Assets: 5.18%

Debt

• Debt-to-Equity Ratio: 11.11
• Current Ratio: 2.60
• Quick Ratio: 1.56

Sales & Book Value

• Annual Sales: £61.34 million
• Price / Sales: 1.07
• Cash Flow: GBX 3.44 per share
• Price / Cash Flow: 7.96
• Book Value: GBX 22.46 per share
• Price / Book: 1.22

Miscellaneous

• Outstanding Shares: 240,081,508
• Free Float: N/A
• Market Cap: £65.64 million
• Optionable: Not Optionable
• Beta: 0.71